MX2021008938A - Goma de mascar de cannabinoide en tabletas con estructura en capas. - Google Patents

Goma de mascar de cannabinoide en tabletas con estructura en capas.

Info

Publication number
MX2021008938A
MX2021008938A MX2021008938A MX2021008938A MX2021008938A MX 2021008938 A MX2021008938 A MX 2021008938A MX 2021008938 A MX2021008938 A MX 2021008938A MX 2021008938 A MX2021008938 A MX 2021008938A MX 2021008938 A MX2021008938 A MX 2021008938A
Authority
MX
Mexico
Prior art keywords
chewing gum
composition
water
layered structure
layer
Prior art date
Application number
MX2021008938A
Other languages
English (en)
Spanish (es)
Inventor
Heidi Ziegler Bruun
Dorte Schackinger Boesen
Ane Eriksen
Original Assignee
Nordiccan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/289,770 external-priority patent/US10799450B2/en
Priority claimed from CA3035400A external-priority patent/CA3035400C/en
Application filed by Nordiccan As filed Critical Nordiccan As
Publication of MX2021008938A publication Critical patent/MX2021008938A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2021008938A 2019-03-01 2019-10-10 Goma de mascar de cannabinoide en tabletas con estructura en capas. MX2021008938A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/289,770 US10799450B2 (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
CA3035400A CA3035400C (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
PCT/DK2019/050308 WO2020177819A1 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with layered structure

Publications (1)

Publication Number Publication Date
MX2021008938A true MX2021008938A (es) 2021-08-24

Family

ID=68617969

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021008938A MX2021008938A (es) 2019-03-01 2019-10-10 Goma de mascar de cannabinoide en tabletas con estructura en capas.

Country Status (9)

Country Link
EP (2) EP4306105B1 (cg-RX-API-DMAC7.html)
JP (1) JP7601779B2 (cg-RX-API-DMAC7.html)
CN (1) CN113423279A (cg-RX-API-DMAC7.html)
AU (1) AU2019432306B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021012489A2 (cg-RX-API-DMAC7.html)
ES (1) ES2970150T3 (cg-RX-API-DMAC7.html)
MX (1) MX2021008938A (cg-RX-API-DMAC7.html)
WO (1) WO2020177819A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202104509B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4058002A4 (en) * 2019-11-12 2024-01-10 London Pharmaceuticals and Research Corporation CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS
WO2024227046A2 (en) * 2023-04-28 2024-10-31 Whelpley Gordon Brittain Iii Spray application of water-soluble actives to drinking vessels and other objects

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71919A1 (cg-RX-API-DMAC7.html) * 1975-02-26 1977-01-06
GB0216413D0 (en) 2002-07-15 2002-08-21 Nestle Sa Tabletted chewing gum sweet
EP1449525A1 (en) 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
EP1554935A1 (en) * 2004-01-19 2005-07-20 Gumlink A/S Layered chewing gum tablet
DK200401195A (da) 2004-08-06 2004-08-06 Gumlink As Layered chewing gum tablet
WO2006063189A2 (en) * 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
DK2229156T3 (en) 2007-12-20 2017-02-06 Fertin Pharma As CHEW GUM TABLE AND PROCEDURE FOR DOSING PHARMACEUTICAL ACTIVE INGREDIENTS IN SUCH CHEW GUM TABLE
US9023322B2 (en) 2008-03-26 2015-05-05 Stichting Sanammad Chewing gum compositions comprising cannabinoids
JP2010252816A (ja) 2010-08-23 2010-11-11 Gumlink As 圧縮チューインガムタブレット
US20140083878A1 (en) 2012-09-21 2014-03-27 Mylan Inc. Transdermal drug delivery device
EP3253368A4 (en) 2015-02-02 2018-08-22 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
ES2843581T3 (es) * 2015-10-07 2021-07-19 Nordiccan As Goma de mascar médica que comprende cannabinoide
CA3025559C (en) * 2016-05-27 2023-08-01 Medcan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
US20180147141A1 (en) 2016-11-29 2018-05-31 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin
US20170265494A1 (en) * 2017-06-05 2017-09-21 International Consolidated Companies, Inc. Chewing gum including nanozome encapsulated cannabidiol

Also Published As

Publication number Publication date
JP2022521711A (ja) 2022-04-12
ZA202104509B (en) 2023-12-20
ES2970150T3 (es) 2024-05-27
EP4306105A2 (en) 2024-01-17
AU2019432306B2 (en) 2023-01-05
JP7601779B2 (ja) 2024-12-17
EP4306105A3 (en) 2024-04-10
BR112021012489A2 (pt) 2021-10-26
EP3876744C0 (en) 2023-12-06
WO2020177819A1 (en) 2020-09-10
AU2019432306A1 (en) 2021-07-08
EP3876744A1 (en) 2021-09-15
CN113423279A (zh) 2021-09-21
EP4306105B1 (en) 2026-06-03
EP3876744B1 (en) 2023-12-06
EP4306105C0 (en) 2026-06-03

Similar Documents

Publication Publication Date Title
Choi et al. Effects of sub‐antimicrobial dose doxycycline therapy on crevicular fluid MMP‐8, and gingival tissue MMP‐9, TIMP‐1 and IL‐6 levels in chronic periodontitis
Ryder et al. Periodontal disease in HIV/AIDS
MX2009010289A (es) Composiciones para administracion nasal.
AR053731A1 (es) Aromatizacion de gomas de mascar que contienen farmacos
ES2192265T3 (es) Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.
CO2023004206A2 (es) Implante de derivación compresible
BRPI0916668A2 (pt) composições e métodos para anticorpos direcionados à proteína do complemento c5
BR112018006259A2 (pt) "adjunto compressível com estruturas de suporte intermediárias"
DOP2006000050A (es) Una formulación sólida de dosificación farmaceútica
CO6501159A2 (es) Formulaciones farmaceuticas de liberación controlada de nitazoxanida
AR034691A1 (es) Composiciones farmaceuticas de administracion oral, que contiene un inhibidor de lipasa gastrointestinal, el comprimido masticable y la galleta que los comprende
EA200970267A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa
Sadeghi et al. Eighteen‐month clinical evaluation of microhybrid, packable and nanofilled resin composites in Class I restorations
CL2024001052A1 (es) Formulaciones y sistemas de erdafitinib para administración intravesical.
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
EP4122483A4 (en) Oral pharmaceutical composition
MX2021012904A (es) Moduladores de la via de respuesta al estres integrada.
EP4253414A4 (en) Anti-tigit antibody, and pharmaceutical composition and use thereof
AR047986A1 (es) Composiciones de pelicula
ZA202104509B (en) Tableted cannabinoid chewing gum with layered structure
AR092356A1 (es) Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion
de Lima et al. Universal cements: dual activated and chemically activated
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
MX2025008705A (es) Sistema para el suministro oral de un ingrediente activo
MX2015012970A (es) Formas de dosificacion solidas de liberacion prolongada antiemeticas.